Level Bio AB (publ) (NGM: LEVBIO)
Sweden
· Delayed Price · Currency is SEK 0.300
0.00 (0.00%)
At close: Nov 22, 2024
Level Bio AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 23.74 | 26.1 | 34.33 | 43.96 | 23.53 | 17.08 | Upgrade
|
| Revenue Growth (YoY) | -18.30% | -23.99% | -21.90% | 86.86% | 37.77% | -5.80% | Upgrade
|
| Cost of Revenue | 12.28 | 13.79 | 19.08 | 26.08 | 14.39 | 9.58 | Upgrade
|
| Gross Profit | 11.46 | 12.31 | 15.25 | 17.88 | 9.14 | 7.49 | Upgrade
|
| Selling, General & Admin | 22.03 | 20.33 | 15.87 | 12.05 | 7.56 | 8.22 | Upgrade
|
| Other Operating Expenses | -0.39 | -0.48 | -0.46 | -0.69 | -0.19 | -0.11 | Upgrade
|
| Operating Expenses | 23.83 | 22.04 | 17.59 | 12.62 | 7.59 | 8.37 | Upgrade
|
| Operating Income | -12.37 | -9.73 | -2.33 | 5.26 | 1.55 | -0.87 | Upgrade
|
| Interest Expense | -0.04 | -0.01 | -0.08 | -0.04 | -0.03 | -0.1 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.05 | 0 | - | 0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | -0 | - | Upgrade
|
| EBT Excluding Unusual Items | -12.39 | -9.69 | -2.41 | 5.21 | 1.52 | -0.97 | Upgrade
|
| Pretax Income | -12.39 | -9.69 | -2.41 | 5.21 | 1.52 | -0.97 | Upgrade
|
| Income Tax Expense | -0.22 | -0.22 | -0.19 | 0.06 | 0.01 | 0.01 | Upgrade
|
| Net Income | -12.18 | -9.48 | -2.22 | 5.16 | 1.51 | -0.98 | Upgrade
|
| Net Income to Common | -12.18 | -9.48 | -2.22 | 5.16 | 1.51 | -0.98 | Upgrade
|
| Net Income Growth | - | - | - | 240.69% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 63 | 63 | 63 | 59 | 53 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 63 | 63 | 63 | 63 | 53 | 53 | Upgrade
|
| Shares Change (YoY) | - | - | - | 20.00% | - | - | Upgrade
|
| EPS (Basic) | -0.19 | -0.15 | -0.04 | 0.09 | 0.03 | -0.02 | Upgrade
|
| EPS (Diluted) | -0.19 | -0.15 | -0.04 | 0.08 | 0.03 | -0.02 | Upgrade
|
| EPS Growth | - | - | - | 179.27% | - | - | Upgrade
|
| Free Cash Flow | -6.57 | -5.49 | 2.79 | 1.63 | 1.84 | 0.07 | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.09 | 0.04 | 0.03 | 0.03 | 0.00 | Upgrade
|
| Gross Margin | 48.26% | 47.16% | 44.43% | 40.67% | 38.83% | 43.88% | Upgrade
|
| Operating Margin | -52.13% | -37.30% | -6.79% | 11.96% | 6.58% | -5.12% | Upgrade
|
| Profit Margin | -51.30% | -36.31% | -6.48% | 11.73% | 6.43% | -5.76% | Upgrade
|
| Free Cash Flow Margin | -27.69% | -21.03% | 8.14% | 3.70% | 7.82% | 0.40% | Upgrade
|
| EBITDA | -11.23 | -8.58 | -1.19 | 5.91 | 1.76 | -0.62 | Upgrade
|
| EBITDA Margin | -47.31% | -32.87% | -3.48% | 13.45% | 7.48% | -3.61% | Upgrade
|
| D&A For EBITDA | 1.14 | 1.15 | 1.14 | 0.65 | 0.21 | 0.26 | Upgrade
|
| EBIT | -12.37 | -9.73 | -2.33 | 5.26 | 1.55 | -0.87 | Upgrade
|
| EBIT Margin | -52.13% | -37.30% | -6.79% | 11.96% | 6.58% | -5.12% | Upgrade
|
| Effective Tax Rate | - | - | - | 1.09% | 0.46% | - | Upgrade
|
| Revenue as Reported | 24.23 | 26.67 | 34.68 | 44.65 | 23.71 | 17.19 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.